For eligible commercially insured patients, program carries a $300 max cap per fill and is subject to an annual limit. You are not eligible if prescriptions are paid by any state or other federally funded programs, including, but not limited to Medicare or Medicaid, Medigap, VA or DOD or TriCare, or where prohibited by law.

QUZYTTIR® (cetirizine hydrochloride injection), for intravenous use


QUZYTTIR is an FDA-approved prescription medicine for the treatment of short-term hives (known as acute urticaria) in adults and children 6 months of age and older.

QUZYTTIR is not recommended in children younger than 6 years old with kidney or liver problems.


  • You should not receive QUZYTTIR if you are allergic to any of its ingredients or if you are allergic to other medicines that contain levocetirizine or hydroxyzine.
  • QUZYTTIR may cause sleepiness. Be careful when driving a car or operating potentially dangerous machinery. Avoid alcohol or taking certain other medicines with QUZYTTIR, as this may raise your risk of having problems with alertness or thinking. Tell the healthcare provider treating you about all the medicines you are taking, including prescription or over-the-counter medicines, vitamins, or herbal supplements.
  • QUZYTTIR was not studied in pregnant or nursing women. Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding.
  • The most common side effects (which occurred in <1% of patients) are: a change in sense of taste, headache, a tingling sensation, feeling faint, indigestion, feeling hot, and excessive sweating.
  • The most common side effects observed in studies of an oral form of the active ingredient in QUZYTTIR taken by adults for a prolonged amount of time were sleepiness, tiredness, dry mouth, sore throat, and dizziness. In similar studies with children, the most common side effects were headache, sore throat, abdominal pain, sleepiness, diarrhea, nosebleed, bronchial spasm, nausea, and vomiting.
  • Call your healthcare provider about any side effects that you may experience

You are encouraged to report negative side effects of prescription drugs to the FDA. To report suspected adverse reactions, contact the FDA at 1-800-FDA-1088 or You may also contact TerSera Therapeutics at 1-844-334-4035 or

For more information, please see the Full Prescribing Information for QUZYTTIR.